Stock Screener App

Frei -

Installieren

68.17

0.09% -0.00

Tarsus Pharmaceuticals Inc (TARS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	27.78% 151.67	118.70	102.66	78.33	66.41
Operating Expenses	19.83% 159.64	133.23	124.84	104.61	90.83
Benefits Costs and Expenses	14.87% 153.03	133.23	124.84	104.61	85.81
Costs And Expenses	19.83% 159.64	133.23	124.84	104.61	90.83
Operating Income/Loss	45.10% -7.976	-14.53	-22.18	-26.28	-24.42
Nonoperating Income/Loss	14.51% 1.662	1.944	1.844	1.16	1.308
Income/Loss From Continuing Operations Before Tax	90.60% -1.366	-14.53	-20.34	-25.12	-19.41
Income/Loss From Continuing Operations After Tax	33.47% -8.373	-12.59	-20.34	-25.12	-23.11
Net Income/Loss	33.47% -8.373	-12.59	-20.34	-25.12	-23.11
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.23% 0.327	42.61	42.36	39.35	0.3176
Diluted Average Shares	99.23% 0.327	42.61	42.36	39.35	0.3176
Basic Earnings Per Share	36.67% -0.19	-0.30	-0.48	-0.64	-0.59
Diluted Earnings Per Share	36.67% -0.19	-0.30	-0.48	-0.64	-0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters